Skip to content
drillr.ai
Sign up

PBH

Prestige Consumer Healthcare Inc.

NYSE · Healthcare · Medical - Distribution · US

$52.26
−0.57%
Ask drillr

  • Aug 21, 2026, 21:00 UTC

    Prestige Brand Holdings recalled 39,060 bottles of Clear Eyes eye drops nationwide due to possible contamination and sterility concerns, as reported by the FDA.

    Source:

  • Aug 14, 2026, 00:00 UTC

    Jeffrey Zerillo retired as Senior Vice President of Operations at Prestige Consumer Healthcare Inc., effective August 14, 2026.

  • Aug 6, 2026, 10:00 UTC

    Prestige Consumer Healthcare Inc. reported its financial results for the first quarter of fiscal 2027, which ended on June 30, 2026.

    Source:

  • Jul 15, 2026, 00:00 UTC

    Prestige Consumer Healthcare Inc. issued $400.0 million of 6.250% Senior Notes due 2034, with interest payable semi-annually starting January 15, 2027, and maturity on July 15, 2034.

  • Jul 6, 2026, 12:00 UTC

    Prestige Consumer Healthcare Inc. announced it will report its first quarter fiscal 2027 results on August 6, 2026.

    Source:

  • Jul 6, 2026, 12:00 UTC

    Prestige Consumer Healthcare Inc. priced a private offering of $400 million in senior notes.

    Source:

  • Jul 6, 2026, 12:00 UTC

    Prestige Consumer Healthcare Inc. completed its acquisition of LaCorium Health.

    Source:

  • Jul 6, 2026, 00:00 UTC

    Prestige Consumer Healthcare Inc. amended its term loan credit agreement to borrow an additional $95 million to finance the LaCorium Acquisition and related fees.

  • Jun 30, 2026, 12:24 UTC

    Prestige Consumer Healthcare Inc.'s subsidiary Prestige Brands, Inc. announced a private offering of $400 million senior notes due 2034.

    Source:

  • Jun 16, 2026, 00:00 UTC

    Prestige Consumer Healthcare Inc. completed the acquisition of the Breathe Right Business from Foundation Consumer Brands, LLC for $1.045 billion in cash, financed with available cash and a new term loan.

    Source: